Dr. Alexander D. Borowsky, M.D.
Pathology (Anatomic Pathology & Clinical Pathology Physician)
- Medicare participating
At a glance
- Medical school
- Vanderbilt University School of Medicine (1994)
- Years since graduation
- 32
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 216
Licensed in California since 2001, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1994Medical school: Vanderbilt University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Anatomic Pathology & Clinical Pathology Physician primary
CA license A77194 (first issued 2001; current) -
Specialist
CA license A77194 (first issued 2001; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UCSF Medical Center San Francisco, CA
Medical groups
- University of California San Francisco (1,839 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 216
- Services billed
- 519
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 372 | 207 |
| Microscopic genetic analysis of tumor, manual | 300 | 89 |
| Special stained specimen slides to examine tissue, each additional procedure | 296 | 68 |
| Pathology examination of tissue using a microscope, moderately high complexity | 264 | 101 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 122 | 110 |
| Special stained specimen slides to examine tissue, initial procedure | 110 | 93 |
| Pathology examination of specimen during surgery, first tissue block | 108 | 42 |
| Special stained specimen slides to identify organisms including interpretation and report | 29 | 13 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 25 | 25 |
| Pathology examination of tissue using a microscope, high complexity | 22 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $1,613 in total to this clinician.
| E.r. Squibb & Sons, L.l.c. | $1,613 |
|---|
| Consulting Fee | $1,613 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| E.r. Squibb & Sons, L.l.c. Oct 27, 2025 | Consulting Fee | $1,613 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.